Stearns V - Search Results

1

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.

Kadakia KC, Snyder CF, Kidwell KM, Seewald NJ, Flockhart DA, Skaar TC, Desta Z, Rae JM, Otte JL, Carpenter JS, Storniolo AM, Hayes DF, Stearns V, Henry NL. Kadakia KC, et al. Among authors: stearns v. Oncologist. 2016 May;21(5):539-46. doi: 10.1634/theoncologist.2015-0349. Epub 2016 Mar 23. Oncologist. 2016. PMID: 27009936 Free PMC article. Clinical Trial.

2

Cooling off hot flashes.

Stearns V, Hayes DF. Stearns V, et al. J Clin Oncol. 2002 Mar 15;20(6):1436-8. doi: 10.1200/JCO.2002.20.6.1436. J Clin Oncol. 2002. PMID: 11896087 No abstract available.

3

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.

Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Stearns V, et al. Ann Surg Oncol. 2002 Apr;9(3):235-42. doi: 10.1007/BF02573060. Ann Surg Oncol. 2002. PMID: 11923129

4

Approach to menopausal symptoms in women with breast cancer.

Stearns V, Hayes DF. Stearns V, et al. Curr Treat Options Oncol. 2002 Apr;3(2):179-90. doi: 10.1007/s11864-002-0064-6. Curr Treat Options Oncol. 2002. PMID: 12057081

5

A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.

Stearns V, Singh B, Tsangaris T, Crawford JG, Novielli A, Ellis MJ, Isaacs C, Pennanen M, Tibery C, Farhad A, Slack R, Hayes DF. Stearns V, et al. Clin Cancer Res. 2003 Jan;9(1):124-33. Clin Cancer Res. 2003. PMID: 12538460

6

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, Hayes DF, Desta Z, Flockhart DA. Stearns V, et al. J Natl Cancer Inst. 2003 Dec 3;95(23):1758-64. doi: 10.1093/jnci/djg108. J Natl Cancer Inst. 2003. PMID: 14652237 Clinical Trial.

7

A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.

Stearns V, Coop A, Singh B, Gallagher A, Yamauchi H, Lieberman R, Pennanen M, Trock B, Hayes DF, Ellis MJ. Stearns V, et al. Clin Cancer Res. 2004 Nov 15;10(22):7583-91. doi: 10.1158/1078-0432.CCR-04-0295. Clin Cancer Res. 2004. PMID: 15569989 Clinical Trial.

8

A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.

Stearns V, Gallagher A, Kleer CG, Singh B, Freedman M, Haddad BR, Isaacs C, Warren R, Brown M, Cullen J, Trock B, Hayes DF. Stearns V, et al. Clin Cancer Res. 2004 Dec 15;10(24):8332-40. doi: 10.1158/1078-0432.CCR-04-0297. Clin Cancer Res. 2004. PMID: 15623610 Clinical Trial.

9

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, Skaar T, Storniolo AM, Li L, Araba A, Blanchard R, Nguyen A, Ullmer L, Hayden J, Lemler S, Weinshilboum RM, Rae JM, Hayes DF, Flockhart DA. Jin Y, et al. Among authors: stearns v. J Natl Cancer Inst. 2005 Jan 5;97(1):30-9. doi: 10.1093/jnci/dji005. J Natl Cancer Inst. 2005. PMID: 15632378

10

CYP2D6 genotype and tamoxifen response.

Rae JM, Goetz MP, Hayes DF, Ingle JN, Li L, Storniolo AM, Stearns V, Flockhart DA. Rae JM, et al. Among authors: stearns v. Breast Cancer Res. 2005 Jul 29;7(5):E6. doi: 10.1186/bcr1297. Breast Cancer Res. 2005. PMID: 16168100 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters